Skip to main content
Fig. 4 | Transplantation Research

Fig. 4

From: Immunomodulating effects of the anti-viral agent Silibinin in liver transplant patients with HCV recurrence

Fig. 4

Correlation analyses between DC markers and clinical parameters. AST, ALT, total bilirubin, HCV RNA, HCV genotype, and IL-28B genotype were analyzed in order to verify possible correlations with circulating DC subsets markers before (Fig. 4ac) and after iv-SIL treatment (Fig. 4dg). DC markers at baseline were also correlated with clinical parameters at the end of iv-SIL treatment (Fig. 4hi)

Back to article page